secwatch.observer — SEC 8-K summary
======================================

Issuer:     PFIZER INC (PFE)
CIK:        0000078003
Form:       8-K
Filed at:   2026-06-18T11:07:07+00:00
Accession:  0000078003-26-000085
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pfizer CFO Dave Denton to step down Aug 15; Cecile Guegan named interim CFO
---------------------------------------------------------------------------

- Dave Denton to step down as CFO effective August 15, 2026, for a consumer goods opportunity.
- Departure not related to Pfizer's financial or operating results or any disagreements.
- Cecile Guegan, SVP Finance, Global Biopharm Business, named interim CFO effective August 16.
- Pfizer will conduct internal and external search for permanent CFO.
- Guegan has over 20 years at Pfizer, led Seagen integration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/pfe-20260618.htm
  HTML page:      https://secwatch.observer/filing/0000078003-26-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer